89BIO LTD has a total of 23 patent applications. It increased the IP activity by 33.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, EPO (European Patent Office) and Israel. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are FAKO ILACLARI A S, FGH BIOTECH INC and JS INNOPHARM SHANGHAI LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Israel | 4 | |
#4 | Canada | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Hudkins Robert L | 8 |
#2 | Zificsak Craig A | 8 |
#3 | Liu Patrick Mengyuan | 6 |
#4 | Zulli Allison L | 6 |
#5 | Kopec Karla K | 6 |
#6 | Dorsey Bruce D | 5 |
#7 | Becknell Nadine C | 5 |
#8 | Gotchev Dimitar B | 5 |
#9 | Weinberg Linda | 5 |
#10 | Dandu Reddeppa Reddy | 5 |
Publication | Filing date | Title |
---|---|---|
KR20200040307A | Mutant FGF-21 peptide conjugates and uses thereof | |
US2020031840A1 | Spiropiperidine derivatives | |
EP3310773A1 | Substituted 4-benzyl and 4-benzoyl piperidine derivatives |